Kidney Function Testing Market Top Companies Study - Beckman Coulter (US), Siemens (Germany), Nova Biomedical (US), Roche (Switzerland), Abbott (US).

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Kidney Function Test Market- (By Product (Dipsticks, Reagents, Disposables), By Type (Urine test (Urine Protein Test, Microalbumin Tests, Creatinine clearance Tests), Blood Test (Serum Creatinine Tests, Glomerular Filtration Rate Tests, Blood Urea Nitrogen Tests)), By End-User (Hospitals, Diagnostics Laboratories, Research Laboratories and Institutes)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Kidney Function Test Market is valued at US$ 863.35 Mn in 2022, and it is expected to reach US$ 1,458.50 Mn by 2031, with a CAGR of 6.08% during a forecast period of 2023-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2139

The kidney function test consists of two primary measures: urine albumin and creatinine levels, alongside a blood test that estimates the glomerular filtration rate (eGFR). These tests provide comprehensive renal data. The test, developed by the company, utilizes disposable cups and strips in conjunction with a smartphone camera to analyze the data, facilitating ease of use and contributing to market growth. Early detection through kidney function testing enables the identification of potential complications from renal diseases, allowing for timely intervention. Kidney function can be classified as either mildly reduced, indicating normal function, or significantly diminished based on the test results.

In summary, the test results categorize kidney function as mildly reduced, normal, or decreased. This classification is expected to drive further market growth, particularly with the increasing global prevalence of chronic kidney disease. However, market expansion may face challenges, including the high cost of diagnostic procedures for kidney disease and regulatory barriers. Recent innovations in the kidney function test market, including new products, market expansion, and the adoption of cutting-edge technologies, are reshaping the industry and stimulating market development.

List of Prominent Players in the kidney function test market:
• Beckman Coulter (US)
• Siemens (Germany)
• Nova Biomedical (US)
• Roche (Switzerland)
• Abbott (US)
• URIT Medical (China)
• ARKRAY (Japan)
• OPTI Medical (US)
• ACON Laboratories (US)
• Sysmex (Japan)
• 77 Elektronika (Hungary)
• Randox Laboratories (UK)
• Quest Diagnostics

Market Dynamics:
Drivers-
The increasing demand for antifog additives is being driven by the rising availability of at-home kidney function tests, coupled with ongoing research and development efforts aimed at expanding the range of innovative products. These factors are expected to significantly contribute to the growth of the kidney function test market in the coming years. As a result of these converging trends, market analysts anticipate continued growth in the global kidney function test market.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Challenges:
A significant challenge to the growth of the global kidney function test market is the potential long-term adverse effects associated with renal medications. Side effects such as loss of appetite, fever, and rashes could impede market expansion, while more serious complications like a decrease in blood cell counts and alterations in liver and kidney function, as indicated by blood tests, pose additional concerns. Gastrointestinal issues such as nausea, vomiting, and diarrhea may also hinder market growth. These side effects, alongside changes in blood test results suggesting liver and kidney disorders, could negatively affect the demand for antifog chemicals. Additionally, the COVID-19 pandemic disrupted healthcare access for individuals with renal conditions. The global lockdowns and restrictions on non-emergency consultations led to delays in the diagnosis and treatment of renal diseases, further impacting the market. During the pandemic, the demand for kidney function tests increased due to the heightened public health risks posed by COVID-19, which led to a higher incidence of renal complications such as proteinuria or hematuria in COVID-19 patients.

Regional Trends:
The Asia-Pacific region is expected to dominate the kidney function test market in terms of revenue share. The market in this region is projected to experience significant growth due to increasing health awareness and a rising demand for advanced diagnostic and therapeutic solutions for chronic renal disorders. In Europe, the market holds a substantial share, supported by increased consumer wealth, a large patient population, and government initiatives aimed at enhancing healthcare and infrastructure. Furthermore, the presence of leading market players and growing collaborations among key industry players for market penetration in the region presents additional opportunities for the expansion of the kidney function test market.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2139

Recent Developments:
• In Sept 2022, The UF-1500 Fully Automated Urine Particle Analyzer (UF-1500) was introduced by Sysmex. The UF-1500 inherits the UF-5000 Fully Automated Urine Particle Analyzer's (UF-5000) high levels of functionality and usability. With the expansion of its product line, will provide a broader selection of solutions tailored to the customer's environment and contribute to the simplification and standardisation of urine testing in small and medium-sized facilities.
• In March 2022, Nova Biomedical introduced a new device to enhance renal care through screening for kidney function and rapid detection of kidney disease in outpatient settings. The new Nova Max Pro Creatinine/eGFR Metre System featured a simplified metre and creatinine biosensor that measured blood creatinine and estimated glomerular filtration rate (eGFR) from a tiny 1.2 microliter capillary fingerstick blood sample in just 30 seconds. These are two important indicators of overall kidney function.

Segmentation of Kidney Function Test Market-
By Product-
• Dipsticks
• Reagents
• Disposables
By Type
• Urine test
o Urine Protein Test
o Microalbumin Tests
o Creatinine clearance Tests
• Blood Test
o Serum Creatinine Tests
o Glomerular Filtration Rate Tests
o Blood Urea Nitrogen Tests
By End-User
• Hospitals
• Diagnostics Laboratories
• Research Laboratories and Institutes
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

View Overview Report: https://www.insightaceanalytic.com/report/kidney-function-test-market/2139

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.